Background: Dosing schedules may be one important factor determining whether patients
take their prescribed medication. Schedules may influence whether a patient stays on the …

BACKGROUND:: The utility of bisphosphonates in the treatment of postmenopausal
osteoporosis is compromised by the requirement of frequent oral administration or complex …

Purpose Major depressive disorder (MDD) has detrimental effects on health-related quality
of life (HRQoL). We describe the effect of vortioxetine on HRQoL in MDD patients by using …

Objective: To compare 2 methods of switching selective serotonin reuptake inhibitor (SSRI)
nonresponders or partial responders to duloxetine. Method: Adult outpatients with DSM-IV …

Guiding clinicians toward the most effective treatment regimens, this reference offers
detailed coverage of the symptomatology, diagnosis, epidemiology, and etiology of …

Background. Approximately half of all treated depressed patients fail to show adequate
response to their initially prescribed antidepressant medication. Switching to another …

Bisphosphonates have been shown to be highly effective in preventing and treating
postmenopausal osteoporosis (PMO) and the associated risk of fracture. However, poor …

This study compared the stabilized duloxetine dose through approximately 12 weeks of
treatment in patients initiating duloxetine therapy with that in patients switching to duloxetine …

Depression is common in primary care and more difficult to treat than many clinicians are
aware. The goal of treatment is symptomatic remission, and by current estimates 50% or …

目的评价氟西汀肠溶片对抑郁症缓解期患者的疗效及安全性. 方法采用随机, 双盲, 活性药对照,
多中心临床研究方法. 按1: 1 将232 例受试者随机分配到氟西汀肠溶片组(116 例) …